Instrument Inactif

Communiqués ICON plc Nasdaq

Actions

US45103T1079

Recherche biotechnologique et médicale

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Communiqués

03/09/13	ICON plc : ICON and DIA to Deliver Webinar on Clinical Outcome Assessments	PU
21/08/13	ICON plc : ICON Launches New Monitoring Service to Improve Quality and Reduce Costs	PU
07/08/13	ICON plc : ICON Signs Collaboration Agreement with the Taiwan National Centre of Excellence for Clinical Trials and Research	PU
25/07/13	ICON plc : ICON Reports second quarter 2013 Revenue of $334 million, up 21% year on year, non-GAAP EPS of 43c and raises FY 2013 Guidance.	PU
23/07/13	ICON plc : ICON shareholders vote in favour of all resolutions at its Annual General Meeting	PU
03/07/13	ICON plc : ICON Appoints Professor Brendan Buckley as Chief Medical Officer	PU
17/06/13	ICON plc : ICON and University College Dublin Launch Innovative Graduate Certificate in Clinical Research	PU
28/05/13	ICON plc : ICON Appoints Dr. Neil McCullough as Executive Vice President of Quality and Compliance and Corporate Training	PU
20/05/13	ICON plc : DOCS Launches New Feature Rich Website	PU
02/05/13	ICON plc : ICON and DIA Deliver Webinar on Optimising Development of New Alzheimer’s Therapies	PU
25/04/13	ICON plc : ICON Reports First Quarter 2013 Revenue of $317 Million, up 26% year on year and non-GAAP EPS of 36c.	BU
24/04/13	ICON plc : ICON Wins ‘Partnership Pioneers of the Year’ Award in Recognition of Global Partnership with Pfizer	PU
24/04/13	ICON plc : ICON Wins 'Partnership Pioneers of the Year' Award in Recognition of Global Partnership with Pfizer	BU
17/04/13	ICON plc : and UCD Smurfit School launch the ICON Business Academy	PU
21/03/13	ICON plc : ICON Launches New ICON Signature Series to Share Expertise and Insight into Clinical Development	PU
21/02/13	ICON plc : ICON Announces Appointment of Professor William Hall to Board of Directors	BU
19/02/13	ICON plc : ICON Reports Fourth Quarter 2012 Revenue of $300 Million, up 24% year on year, EPS of 34c and Full Year revenue of $1.12 billion, EPS of $1.00.	BU
19/02/13	ICON plc : Cross Country Healthcare Completes Sale of Its Clinical Trial Services Business	BU
11/02/13	ICON plc : ICON and DIA Collaborate to Deliver New Educational Product	PU
05/02/13	ICON plc : ICON Announces the Commencement of Direct Trading on NASDAQ	BU
04/02/13	ICON plc : ICON To Acquire Clinical Trial Services Division of Cross Country Healthcare Inc	PU
04/02/13	ICON plc : ICON To Acquire Clinical Trial Services Division of Cross Country Healthcare, Inc.	BU
14/01/13	ICON plc : ICON Appoints Robert Howie as Chief Marketing Officer	PU
10/01/13	ICON plc : ICON and Cerner team up to streamline Late Phase Research Studies	PU
21/12/12	ICON plc : Mr. Thomas Lynch Elected as Chairman of ICON plc	BU